Insider Trading Activity BeiGene, Ltd. (NASDAQ:BGNE) – Director Bought 176,056 shares of Stock

ME Staff
-
0

Insider Trading Activity For BeiGene, Ltd. (NASDAQ:BGNE)

Bros. Advisors Lp Baker , Director of BeiGene, Ltd. (NASDAQ:BGNE) reportedly Bought 176,056 shares of the company’s stock at an average price of 71 for a total transaction amount of $12,499,976.00 SEC Form

Insider Trading History For BeiGene, Ltd. (NASDAQ:BGNE)

  • On 2/8/2016 Ruirong Yuan, Insider, bought 130,000 with an average share price of $1.85 per share and the total transaction amounting to $240,500.00.View SEC Filing
  • On 2/8/2016 Howard Liang, CFO, bought 65,000 with an average share price of $1.85 per share and the total transaction amounting to $120,250.00.View SEC Filing
  • On 2/8/2016 Bros. Advisors Lp Baker, Director, bought 1,912,680 with an average share price of $24.00 per share and the total transaction amounting to $45,904,320.00.View SEC Filing
  • On 9/21/2016 Donald W Glazer, Director, sold 67,252 with an average share price of $31.42 per share and the total transaction amounting to $2,113,057.84.View SEC Filing
  • On 9/23/2016 Donald W Glazer, Director, sold 36,443 with an average share price of $31.02 per share and the total transaction amounting to $1,130,461.86.View SEC Filing
  • On 9/27/2016 Donald W Glazer, Director, sold 47,149 with an average share price of $29.61 per share and the total transaction amounting to $1,396,081.89.View SEC Filing
  • On 9/28/2016 Donald W Glazer, Director, sold 41,463 with an average share price of $30.66 per share and the total transaction amounting to $1,271,255.58.View SEC Filing

    • Analyst Ratings For BeiGene, Ltd. (NASDAQ:BGNE)
    These are 6 Buy Ratings .
    The current consensus rating for BeiGene, Ltd. (NASDAQ:BGNE) is Buy (Score: 3.00) with a consensus target price of $73.75 , a potential (3.36% upside)

    Analyst Ratings History For BeiGene, Ltd. (NASDAQ:BGNE)

    • On 2/29/2016 Goldman Sachs Group, Inc. (The) Initiated Coverage of rating Buy with a price target of $33.00
    • On 10/7/2016 Cowen and Company Reiterated Rating Buy
    • On 6/1/2017 William Blair Reiterated Rating Outperform
    • On 7/6/2017 Robert W. Baird Boost Price Target of rating Outperform with a price target of $44.00 to $58.00
    • On 7/7/2017 Maxim Group Boost Price Target of rating Buy with a price target of $57.00 to $73.00
    • On 7/10/2017 Morgan Stanley Reiterated Rating Overweight with a price target of $83.00
    • On 8/7/2017 Ladenburg Thalmann Financial Services Initiated Coverage of rating Buy to Buy with a price target of $81.00

    Recent Trading Activity for BeiGene, Ltd. (NASDAQ:BGNE)
    Shares of BeiGene, Ltd. closed the previous trading session at 71.35 up +0.33 0.46% with 770,293 shares trading hands.